[1]
“Long-Term Toxicity and Survival Outcomes After Stereotactic Ablative Radiotherapy for Patients With Centrally Located Thoracic Tumors: SABR for Central Thoracic Tumors”, Radiol Oncol, vol. 54, no. 4, pp. 480–487, Nov. 2020, Accessed: Oct. 22, 2026. Available: https://www.radioloncol.com/index.php/ro/article/view/3439